All articles by Chemistry World – Page 45
-
Opinion
Letters: May 2007
From Peter Plesch I wish to challenge Ted Nield’s Comment piece (Chemistry World, March 2007, p38). As chair of the Association of British Science Writers, he should know better than to lump together science and technology. Science is about finding and developing ideas about Nature in the widest ...
-
Business
Business roundup: May 2007
US chemical plant security legislation The US Department of Homeland Security (DHS) has released its final list of federal security regulations governing US chemical plants. The 2001 terrorist attacks in New York brought security measures under scrutiny, but with America on high alert many felt that chemical ...
-
News
News in brief: May 2007
Caves of crystal Geologists have explained how the giant crystals in Mexico’s Cueva de los Cristales, Naica, were formed. The 11-metre-long translucent gypsum beams are among the largest in the world. Subsiding volcanic activity kept the temperature at 58°C - the transition temperature between anhydrite (pure calcium ...
-
News
European generics suppliers hit
European patent office reinstates patent for Merck's third biggest drug, Fosamax
-
Podcast
April 2007
Chemistry World Podcast - April 2007(Promo)Brought to you by the Royal Society of Chemistry: The Chemistry World podcast.(End Promo)Interviewer - Chris SmithHello and welcome to the Chemistry World podcast, this is episode number 7 with Chemistry World''s editor Mark Peplow... Interviewee - Mark PeplowHello!Interviewer - Chris SmithWith Deputy Editor Bea ...
-
News
Sanofi-aventis and Oxford BioMedica enter licensing agreement
Oxford BioMedica has licensed its leading cancer drug, TroVax, to Sanofi-aventis
-
Opinion
Letters: April 2007
From Clifford Jones In the UK, batches of faulty petrol were recently found to have been contaminated with silicon (see p11). Burning this fuel would have formed silica (SiO2) particles which clogged the oxygen sensor at the exhaust, causing it to fail in its role in ’engine management’. ...
-
Business
Business roundup: April 2007
Pharma’s house of cards Anglo-Swedish drug company AstraZeneca has announced plans to cut roughly 700 jobs at its site in Macclesfield, UK. A further 850 staff will go at Swedish production facilities. The news marks the first step in the implementation of the company’s plans to cut 3000 jobs from ...
-
News
Testing times for 'mega-pharma'
Industry experts address what can be done to stop big pharma from engineering its own demise.
-
News
Akzo Nobel sells medicines business to Schering Plough
Organon, the pharmaceuticals and animal health business, has been sold for 11 billion euros (£7.5 billion).
-
Opinion
Letters: March 2007
From Clive Delmonte Sir John O’Reilly’s comment on peer review covers many pertinent points, but I feel there is a further crucial aspect to consider (Chemistry World, February 2007, p36). The accepted paradigms in science are that non-experts defer to the opinion of experts, while the experts ...
-
Podcast
March 2007
Chemistry World Podcast - March 2007(Promo)Brought to you by the Royal Society of Chemistry, the Chemistry World Podcast.(End Promo)Interviewer - Chris Smith Hello and welcome to episode 6 of the Chemistry World podcast with editor, Mark Peplow... Interviewee - Mark PeplowHello!Interviewer - Chris SmithScience correspondent Richard Van Noorden... Interviewee - ...
-
Business
Business roundup: March 2007
Novartis contests India’s patent law Swiss pharmaceutical company Novartis is suing the Indian government for contravening international patent agreements. The company accuses the Indian government of failing to comply with World Trade Organization (WTO) rules after it refused to grant the company a patent on its cancer drug ...
-
Podcast
February 2007
Chemistry World Podcast - February 2007 (Promo) Brought to you by the Royal Society of Chemistry, the Chemistry World Podcast. (End Promo) Interviewer - Chris Smith Hello and welcome to episode 5 of the Chemistry World podcast with me Chris Smith, with Editor, Mark Peplow... Interviewee -Mark Peplow ...